<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03480373</url>
  </required_header>
  <id_info>
    <org_study_id>17-180-6</org_study_id>
    <secondary_id>5R01CA207491-04</secondary_id>
    <nct_id>NCT03480373</nct_id>
  </id_info>
  <brief_title>Electronic Cigarette Use During Pregnancy</brief_title>
  <official_title>Electronic Cigarette Use During Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UConn Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hartford Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Roswell Park Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Denver Health Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baystate Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>East Tennessee State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>UConn Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim 1: To compare the overall toxicant exposure in pregnant women who use electronic&#xD;
      cigarettes (e-cigs, vapor, e-liquid, e-juice, vape, vaping devices) compared to women who&#xD;
      smoke conventional cigarettes.&#xD;
&#xD;
      Aim 2. To compare toxicant exposure and birth outcomes among infants born to pregnant women&#xD;
      who use e-cigs compared to women who smoke conventional cigarettes.&#xD;
&#xD;
      Aim 3. To explore potential mechanisms by which e-cigs could influence birth weight.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In addition to examining characteristics of pregnant e-cig users as well as patterns of their&#xD;
      product use, this study is innovative in several ways. First, it is the first known study to&#xD;
      examine toxicant exposure to cigarettes and e-cigs in a sample of pregnant smokers who are&#xD;
      using these products. Although studies have reported on toxic exposures with e-cigs, this is&#xD;
      the first study to apply toxic exposure tests to pregnant women.&#xD;
&#xD;
      Second this is the first study to examine the impact of electronic cigarette use on birth&#xD;
      outcomes in pregnant smokers. Although e-cigarettes are similar to tobacco cigarettes in that&#xD;
      they deliver nicotine, they are distinguished from tobacco cigarettes in that they do not&#xD;
      contain many toxic substances such as carbon monoxide and volatile organic compounds.&#xD;
      Consequently, similar to nicotine replacement therapies they have the potential to improve&#xD;
      birth outcomes. However, it possible that there may be unanticipated negative effects on&#xD;
      birth outcomes, and this study could provide a signal for potential other adverse effects&#xD;
      (i.e., miscarriages etc.). Third, this study is the first to examine whether e-cigs alter&#xD;
      carcinogen exposure to the fetus, which has been implicated in causing low birth weight and&#xD;
      in long-term cancer risk for infants born to smokers. Finally, this is the first study to&#xD;
      explore formaldehyde in urine as a measurement of conventional smoking and electronic&#xD;
      cigarette use.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 18, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the overall toxicant exposure in pregnant women who use electronic cigarettes compared to women who smoke conventional cigarettes.</measure>
    <time_frame>9 months</time_frame>
    <description>The overall toxicant exposure will be measured at each trimester and adjusted for potential confounding covariates. A multivariate analysis of variance (MANOVA) with repeated measures will be used to evaluate the pregnant women who use electronic cigarettes compared to women who smoke conventional cigarettes at each trimester.</description>
  </primary_outcome>
  <enrollment type="Anticipated">375</enrollment>
  <condition>Cigarette Smoking-Related Carcinoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        -  Age: at least 16 years of age&#xD;
&#xD;
          -  Ethnicity: Hispanic and non-Hispanic. All race and ethnic groups will be eligible&#xD;
&#xD;
          -  Gender: Female&#xD;
&#xD;
          -  Other characteristics - (e.g. primary language etc.): English or Spanish speaking&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. cigarette smokers who exclusively smoke conventional cigarettes daily, or who use&#xD;
             e-cigs daily, or who use either product daily and the other product at least weekly.&#xD;
&#xD;
          2. Participant is ≤ 24 weeks gestation for conventional smokers and ≤ 36 weeks gestation&#xD;
             for e-cig users or dual users.&#xD;
&#xD;
          3. at least 16 years of age&#xD;
&#xD;
          4. able to speak English or Spanish;&#xD;
&#xD;
          5. able to read and sign consent form&#xD;
&#xD;
          6. intent to carry pregnancy to term.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. current drug or alcohol abuse or dependence (other than methadone or buprenorphine&#xD;
             maintenance)&#xD;
&#xD;
          2. participant uses combustible marijuana more than 3 times per week (use of edibles/oils&#xD;
             is permitted&#xD;
&#xD;
          3. unstable psychiatric disorder&#xD;
&#xD;
          4. unstable medical problems (e.g., pre-eclampsia, threatened abortion, hyperemesis&#xD;
             gravidarum)&#xD;
&#xD;
          5. known congenital abnormality&#xD;
&#xD;
          6. Regular use of tobacco products other than conventional or e-cigs&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Erin Mead-Morse, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>UConn Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marla Genova, MA</last_name>
    <phone>860-679-4647</phone>
    <email>mgenova@uchc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sheila Thurlow, MSN, RN</last_name>
    <phone>860-679-4637</phone>
    <email>thurlow@uchc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chloe Banel, BS</last_name>
      <phone>303-724-2028</phone>
      <email>chloe.banel@cuanschutz.edu</email>
    </contact>
    <investigator>
      <last_name>Kent S Hjerpe, MD, FACOG</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Denver Health Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chloe Banel, BS</last_name>
      <phone>303-724-2028</phone>
      <email>chloe.banel@cuanschutz.edu</email>
    </contact>
    <investigator>
      <last_name>Nicki Nguyen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCONN Health</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marla Genova, M.A.</last_name>
      <phone>860-679-4647</phone>
      <email>mgenova@uchc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sheila Thurlow, MSN, RN</last_name>
      <phone>860-679-4637</phone>
      <email>thurlow@uchc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Erin Mead-Morse, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's Ambulatory Health Services at Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Mullins, MD</last_name>
      <phone>860-972-1335</phone>
      <email>jessica.mullins@hhchealth.org</email>
    </contact>
    <investigator>
      <last_name>Ellen Dornelas, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiki Govantes</last_name>
      <phone>413-333-8508</phone>
      <email>Tiki.Govantes@Baystatehealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>East Tennessee State University</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <zip>37614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Sheets, MA</last_name>
      <phone>276-469-5134</phone>
      <email>SHEETSKE@mail.etsu.edu</email>
    </contact>
    <investigator>
      <last_name>Beth Bailey, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 21, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>April 19, 2021</last_update_submitted>
  <last_update_submitted_qc>April 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UConn Health</investigator_affiliation>
    <investigator_full_name>Erin Mead-Morse</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Nicotine</keyword>
  <keyword>Nicotine addiction</keyword>
  <keyword>Tobacco Use Disorder</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Electronic cigarettes</keyword>
  <keyword>Cigarettes</keyword>
  <keyword>Vaping</keyword>
  <keyword>Carcinoma</keyword>
  <keyword>Pregnant</keyword>
  <keyword>Birth Outcomes</keyword>
  <keyword>E-liquid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

